Beta Drugs Ltd.
Snapshot View

631.00 +2.75 ▲0.4%

31 January 2023, 11:53:58 AM
Volume: 1,000

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.betadrugslimited.com
Market Cap 605.67 Cr.
Enterprise Value(EV) 607.27 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 25.83 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 24.39 Trailing Twelve Months Ending 2022-03
Industry PE 32.78 Trailing Twelve Months Ending 2022-03
Book Value / Share 96.05 Trailing Twelve Months Ending 2022-03
Price to Book Value 6.56 Calculated using Price: 630.00
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.96 Cr. 9,613,790 Shares
FaceValue 10
Company Profile
Beta Drugs is pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers. Beta Drugs is primarily engaged in the manufacturing of oncology products. The products include anti-cancer tablets, capsules, injections and lyophilized injections. Company has portfolio of over 50 products which is used for the treatment of various cancer diseases. Beta Drugs is a part of Adley Group, which was founded in the year 1985. Company's manufacturing unit is located at Solan, Himachal Pradesh.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.44%
1 Week
-2.92%
1 Month
-11.13%
3 Month
-12.97%
6 Month
-22.39%
1 Year
+1.61%
2 Year
+450.85%
5 Year
+272.27%
10 Year
5 years 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 20.57 21.79 19.21 18.65 30.85
Return on Capital Employed (%) 19.36 18.41 20.71 22.17 36.38
Return on Assets (%) 13.64 12.10 9.82 10.26 17.53

Balance Sheet View Details >>

Particulars 5 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 33 41 57 69 92
Non Curr. Liab. 3 9 13 15 16
Curr. Liab. 14 33 38 37 55
Minority Int.
Equity & Liab. 50 83 108 120 163
Non Curr. Assets 17 39 51 49 60
Curr. Assets 32 44 57 71 103
Misc. Exp. not W/O
Total Assets 50 83 108 120 163

Profit Loss View Details >>

Particulars 5 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Net Sales 51 66 91 116 184
Other Income 0 0 0 1 1
Total Income 51 66 91 117 185
Total Expenditure -41 -54 -73 -91 -141
PBIDT 10 12 18 25 43
Interest -1 -1 -3 -2 -2
Depreciation -2 -3 -4 -7 -7
Taxation 0 0 -3 -4 -9
Exceptional Items
PAT 7 8 9 12 25
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 7 8 9 12 25
Adjusted EPS 8 9 10 12 26

Cash Flow View Details >>

Particulars 5 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 17 0 8 19 30
Cash Fr. Inv. -11 -21 -15 -6 -22
Cash Fr. Finan. 5 12 9 -8 -1
Net Change 12 -9 2 5 7
Cash & Cash Eqvt 12 3 5 10 17

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 66.68 66.68 66.68 66.68 66.71 66.71 66.71 66.71 66.71
Public 33.32 33.32 33.33 33.31 33.29 33.29 33.29 33.29 33.29
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

No Corporate Announcement found.

Technical Scans View Details >>

Mon, 30 Jan 2023
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 252,338.06 1,038.85 -1.2%
Divi's Laboratories Ltd. 89,367.34 3,344.95 -0.6%
Cipla Ltd. 83,741.18 1,027.30 -0.7%
Dr. Reddy's Laboratories Ltd. 72,084.75 4,330.00 +0.0%
Apollo Hospitals Enterprise Ltd. 61,094.10 4,273.25 +0.8%
Torrent Pharmaceuticals Ltd. 52,291.51 1,518.20 -1.9%
Abbott India Ltd. 44,555.01 20,966.90 -0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 61.43 1,038.85 -1.2%
Divi's Laboratories Ltd. Consolidated 2022-09 29.89 3,344.95 -0.6%
Cipla Ltd. Consolidated 2022-12 31.74 1,027.30 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.79 4,330.00 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.76 4,273.25 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.93 1,518.20 -1.9%
Abbott India Ltd. Standalone 2022-09 50.53 20,966.90 -0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.75 1,038.85 -1.2%
Divi's Laboratories Ltd. Consolidated 2022-09 7.37 3,344.95 -0.6%
Cipla Ltd. Consolidated 2022-12 3.69 1,027.30 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.28 4,330.00 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.21 4,273.25 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.20 1,518.20 -1.9%
Abbott India Ltd. Standalone 2022-09 16.41 20,966.90 -0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,038.85 -1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,344.95 -0.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,027.30 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,330.00 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,273.25 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,518.20 -1.9%
Abbott India Ltd. Standalone 2022-03 0.00 20,966.90 -0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,038.85 -1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,344.95 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,027.30 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,330.00 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,273.25 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,518.20 -1.9%
Abbott India Ltd. Standalone 2022-03 29.95 20,966.90 -0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,038.85 -1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,344.95 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,027.30 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,330.00 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,273.25 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,518.20 -1.9%
Abbott India Ltd. Standalone 2022-03 29.95 20,966.90 -0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,038.85 -1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,344.95 -0.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,027.30 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,330.00 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,273.25 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,518.20 -1.9%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,966.90 -0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,038.85 -1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,344.95 -0.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,027.30 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,330.00 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,273.25 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,518.20 -1.9%
Abbott India Ltd. Standalone 2022-03 798.70 20,966.90 -0.1%

FAQ's On Beta Drugs Ltd.

What is Beta Drugs share price?

Can I buy Beta Drugs shares now?

What is the Market Cap of Beta Drugs?

What are the key metrics to analyse Beta Drugs?

What is the 52 Week High and Low of Beta Drugs?

What is the trend of Beta Drugs share price?